Stroke is one of the leading causes of death and disability around the world. It happens when blood flow to the brain is blocked or reduced, which can damage brain cells within minutes.
Many strokes are caused by blood clots that travel to the brain. Because of this, doctors often focus on finding ways to prevent clots before they form.
A study has brought attention to a hidden heart condition that may quietly increase the risk of stroke. This condition is called sub-clinical atrial fibrillation, or SCAF. It is a type of irregular heartbeat, but unlike regular atrial fibrillation, it often does not cause clear symptoms. Many people with SCAF feel completely normal and do not know they have it.
Because SCAF does not usually show symptoms, it is difficult to detect using standard medical tests. Instead, it is often found by accident through special devices such as implanted heart monitors or wearable technology.
These devices can track the heart’s rhythm over long periods and pick up short episodes of irregular beating that would otherwise go unnoticed.
Even though SCAF may seem mild, it can still increase the risk of stroke. When the heart does not beat in a regular pattern, blood may not flow smoothly. This can allow clots to form, and if a clot travels to the brain, it can cause a stroke. This makes SCAF an important condition for doctors to understand and manage.
The new study, led by Dr. Jeff Healey from the Population Health Research Institute, looked at whether a common blood-thinning medicine called apixaban could help reduce this risk. The study followed more than 4,000 people from 16 different countries over a period of eight years. All of the participants had SCAF and were considered at risk of stroke.
Apixaban is a medication that helps prevent blood clots by reducing the blood’s ability to clot too easily. It is already widely used for patients with known atrial fibrillation. In this study, researchers wanted to see if it could also help people with SCAF, even though their condition is less obvious.
The results were very encouraging. People who took apixaban had a 37 percent lower risk of stroke or other serious blood clots compared to those who did not take the medication. Even more importantly, the number of fatal or disabling strokes was reduced by 49 percent.
This shows that the drug not only lowers the chance of having a stroke but also reduces the severity of strokes when they do occur.
Like all medications, apixaban does have some risks. The study found that it increased the chance of major bleeding. However, most of these bleeding events were not life-threatening and could be treated. For many patients, the benefit of preventing a serious stroke may be greater than the risk of bleeding.
The findings of this study were published in the New England Journal of Medicine and presented at the American Heart Association Scientific Sessions. These are both highly respected sources in the medical field, which means the results are taken seriously by doctors and researchers around the world.
This research could change how doctors treat patients with hidden heart rhythm problems. As more people use wearable devices like smartwatches, it is becoming easier to detect conditions like SCAF early. This creates an opportunity to start treatment before a stroke happens.
In the future, doctors may begin to recommend blood thinners like apixaban for more patients who have SCAF and other risk factors for stroke. This could help prevent many strokes and save lives.
Researchers also note that stroke prevention is not only about medication. Healthy lifestyle choices can also play an important role. Diets rich in fruits, vegetables, and nutrients such as flavonoids may help protect the heart and brain.
The MIND diet, which combines elements of the Mediterranean and DASH diets, has also been linked to better brain health. Other studies suggest that antioxidants, as well as regular consumption of tea and coffee, may support heart and brain function.
Overall, this study highlights the importance of detecting hidden heart conditions and treating them early. It shows that even a silent problem like SCAF can have serious effects, but with the right treatment, those risks can be reduced.
As technology and research continue to improve, more people may be able to protect themselves from stroke and live longer, healthier lives.
If you care about stroke, please read studies about how to eat to prevent stroke, and diets high in flavonoids could help reduce stroke risk.
For more health information, please see recent studies about how Mediterranean diet could protect your brain health, and wild blueberries can benefit your heart and brain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
